Switching Between Biologics and Biosimilars in Inflammatory Bowel Disease

Laura E. H. Raffals, Geoffrey C. Nguyen, David T. Rubin

Research output: Contribution to journalArticle

2 Citations (Scopus)
Original languageEnglish (US)
JournalClinical Gastroenterology and Hepatology
DOIs
StatePublished - Jan 1 2019

Fingerprint

Biosimilar Pharmaceuticals
Biological Products
Inflammatory Bowel Diseases

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology

Cite this

Switching Between Biologics and Biosimilars in Inflammatory Bowel Disease. / Raffals, Laura E. H.; Nguyen, Geoffrey C.; Rubin, David T.

In: Clinical Gastroenterology and Hepatology, 01.01.2019.

Research output: Contribution to journalArticle

@article{5d7b9f627eac469897fbf52d78e5457e,
title = "Switching Between Biologics and Biosimilars in Inflammatory Bowel Disease",
author = "Raffals, {Laura E. H.} and Nguyen, {Geoffrey C.} and Rubin, {David T.}",
year = "2019",
month = "1",
day = "1",
doi = "10.1016/j.cgh.2018.08.064",
language = "English (US)",
journal = "Clinical Gastroenterology and Hepatology",
issn = "1542-3565",
publisher = "W.B. Saunders Ltd",

}

TY - JOUR

T1 - Switching Between Biologics and Biosimilars in Inflammatory Bowel Disease

AU - Raffals, Laura E. H.

AU - Nguyen, Geoffrey C.

AU - Rubin, David T.

PY - 2019/1/1

Y1 - 2019/1/1

UR - http://www.scopus.com/inward/record.url?scp=85061998267&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85061998267&partnerID=8YFLogxK

U2 - 10.1016/j.cgh.2018.08.064

DO - 10.1016/j.cgh.2018.08.064

M3 - Article

C2 - 30196164

AN - SCOPUS:85061998267

JO - Clinical Gastroenterology and Hepatology

JF - Clinical Gastroenterology and Hepatology

SN - 1542-3565

ER -